Press "Enter" to skip to content

Rowkins Capital News

Second Investment announced in SafeRx

We are proud to announce that we have just completed our second investment in our portfolio company SafeRX Pharmaceuticals SafeRX is at the leading edge of the war against opioid abuse. Their platform is designed to deliver a range of Opiod medications that avoid both the danger of being taken (inappropriately) with alcohol and avoiding the body’s natural tendency to need ever growing doses to maintain pain relief. Hot on the heels of several multi billion dollar lawsuits against pharma…